Analgesics in Georgia records strong growth in 2026, supported by steady demand for everyday pain relief, although increasing interest in preventive health tempers volume growth as consumers adopt more holistic approaches to wellbeing. Topical analgesics/anaesthetic performs strongly, while wider digital availability improves access and purchasing convenience. Stricter GMP requirements reshape competition as non-compliant brands and imports exit, resulting in a moderately concentrated landscape dominated by fewer, stronger players. Sopharma maintains its lead through GMP-certified production quality, a broad product range and strong distribution partnerships. Pharmacies remains the dominant route to market, while pharmacy-led e-commerce complements established store networks through digital ordering, flexible collection and rapid delivery. Looking ahead, analgesics is expected to maintain growth as continued GMP enforcement favours certified international brands and major local producers. Preventive health is poised to constrain volume growth, although Georgia's ageing population is expected to sustain demand for pain relief. Pharmacy-led e-commerce is also anticipated to gain further traction as established chains strengthen the integration of physical and digital retail.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Georgia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Georgia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Georgia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Georgia?
- Which are the leading brands in Analgesics in Georgia?
- How are products distributed in Analgesics in Georgia?
- How has the regulatory and operating environment for Analgesics changed in Georgia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Prevention shift slows volume growth as consumers adopt holistic health approaches
E-commerce expands access to a wider assortment of analgesics
GMP enforcement drives consolidation as non-compliant players exit
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Stricter GMP enforcement set to favour compliant players as consolidation continues
Preventive health poised to temper volume growth as ageing sustains demand
E-commerce expansion poised to widen access and reshape the retail mix
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Regulatory change concentrates share among leading players
Compliance and distribution strength underpin Sopharma’s lead
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Extensive networks and consumer trust sustain pharmacy dominance
PSP extends pharmacy reach through digital ordering and flexible fulfilment
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!